- This event has passed.
March 12, 2020
March 12, 2020 @ 5:00 pm - 6:00 pm EDT
Zealand Pharma Annual Report for full year 2019
Zealand Pharma hosts conference call on March 12 at 4 pm CET (11 am EDT) to present full year results for 2019
Note: The scheduled time of the conference call has been adjusted for daylight savings time in the U.S.: from 10 AM Eastern Standard Time to 11 AM Eastern Daylight Time.
Presenting during the call will be President and Chief Executive Officer Emmanuel Dulac, Senior Vice President and Chief Financial Officer Matt Dallas, and Executive Vice President and Chief Medical Officer Adam Steensberg. The presentation will be followed by a Q&A session. The conference call will be conducted in English, and the dial-in numbers are:
Denmark, Copenhagen…………… +45 32 72 80 42
United Kingdom…………………….. +44 (0) 844 571 8892
United States………………………… +1 631 510 7495
France, Paris…………………………. +33 (0) 176700794
Netherlands, Amsterdam ……….. +31 (0) 207143545
Confirmation Code: …………………. 4386995
A live audio webcast of the call, including an accompanying slide presentation, will be available via the following link, https://edge.media-server.com/mmc/p/us9w9frz
Participants are advised to register for the webcast at least 10 minutes before the scheduled start.
A recording of the event and a transcript will be available on the Investor section of Zealand’s website after the call.
For further information, please contact:
Zealand Pharma Investor Relations
+45 50 60 38 00 investors@zealandpharma.com
Lani Pollworth Morvan, Investor Relations and Communication
lpm@zealandpharma.com